Latest news
Imugene Reports Azer-cel Clinical Responses and Schedules EGM for Tranche 2 Placement Approval - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMTAnnexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 10:01:15 GMTAnnexon, Inc. Reports Early Clinical Responses in First U.S. and European Patient Cohort of GBS FORWARD Study with Tanruprubart - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 15:47:18 GMT